We’re proud to share that Velocity Clinical Research has joined Advarra’s newly launched Council for Responsible Use of AI in Clinical Trials as a founding member—alongside fellow industry leaders from Sanofi and Recursion.
This cross-industry initiative will focus on setting standards, defining measurable outcomes, and guiding the ethical use of AI across the clinical trial lifecycle. Together, we’re working to turn AI’s potential into tangible improvements in study design, operational efficiency, and—most importantly—patient outcomes.
Thank you to Advarra for convening this vital conversation and driving responsible innovation forward.
Read the full announcement: https://www.advarra.com/news/advarra-establishes-ai-council-in-partnership-with-life-sciences-leaders-to-drive-collaboration-and-advance-innovation-in-clinical-trials/
